News

Esperto is thrilled to be named among the ten finalists for the UCSF-Stanford Pediatric Device Accelerator competition. Esperto was selected from over 60 applicants for the chance to win up to $100,000 to advance its wearable pediatric vital sign monitor towards clinical testing and marketing clearance. Esperto’s technology measures blood pressure directly and noninvasively using acoustics, offering the possibility to obtain accurate, continuous vital sign data without needles or uncomfortable squeezing cuffs. Winners will be selected at the 5th annual Michael R. Harrison Innovation Symposium on March 22, 2024 in San Francisco.

Bringing new medical technologies to the marketplace is a long expensive process that requires a variety of skills and resources. It can be even more challenging for women and other underrepresented entrepreneurs in biotechnology. Alaina Rajagopal, M.D., Ph.D., spent decades training to be a scientist and physician, but when she co-founded a start-up to bring a non-invasive continuous blood pressure device to customers, she wanted to learn more about entrepreneurship. (more...).

Esperto’s first publication detailing its novel technique for continuous, noninvasive, calibration-free blood pressure measurement is now available on the preprint server medRxiv. Lead author Raymond Jimenez and colleagues describe the company’s patented ‘Resonance Sonomanometry’ technique and present the results of its initial clinical validation in humans. (more...).

Esperto has secured an investment from the Bill and Melinda Gates Foundation to advance its novel ultrasound-based continuous noninvasive blood pressure measurement device to improve monitoring of pregnant women in low-to-middle income countries (LMICs). Pregnant women are notoriously underdiagnosed and undertreated by the medical community. This is especially true in LMICs, where lack of medical resources and remote location can make monitoring during pregnancy difficult or impossible. For women who reside in traditionally underserved areas, Esperto’s technology could prove lifesaving by longitudinally collecting vital sign data and automatically uploading it to the cloud, enabling a clinician to access the information without the woman ever having to come to the office.

Esperto is proud to be one of ten finalists in the Alliance for Pediatric Device Innovation (APDI) and the Consortium For Technology & Innovation in Pediatrics (CTIP)’s 2023 Make Your Medical Device Pitch for Kids! ™ competition. Children experience serious complications from arterial catheterization at 10 times the rate of adults. By removing the need for invasive blood pressure monitoring, Esperto promises to make intensive care monitoring safer and more comfortable for kids. Esperto will pitch its solution at Children’s National Hospital’s 11th Annual Symposium on Pediatric Device Innovation at the Anaheim Convention Center on Sunday, October 8, 2023 for the chance to win up to $50,000.

Esperto Medical has been named a finalist in Octane’s 2023 High Tech Awards in the Ones to Watch category. The High Tech Awards recognize the best and brightest minds in the industry, those who are pushing boundaries and redefining what's possible. Esperto will be honored with the other finalists at the High Tech Awards gala in Irvine on September 21, 2023. (more...).

Esperto is among the 50 semifinalists for the 2023 U.S. Army xTechPrime competition. xTechPrime challenges small businesses to work together in teams with technology integrators to submit their innovative solutions that contribute to the Army’s current modernization goals. As a winner of the first phase of competition, Esperto receives a cash prize of $5000 along with invitations to participate in both the Army’s xTech Accelerator program and the xTech Collider event at the FedSupernova conference in Austin, TX on August 23, 2023. Ultimately, 15 small businesses will be chosen for a $20,000 prize and the opportunity to submit a proposal for a potential Direct to Phase II Army SBIR contract valued up to $1.9 million.